Skip to main content

Research Repository

Advanced Search

Specialist treatment for persistent depression in secondary care: Sustained effects from a multicentre UK study at 24 and 36 months

Nixon, Neil; Guo, Boliang; Kaylor-Hughes, Catherine; Simpson, Sandra; Garland, Anne; Dalgleish, Tim; Morriss, Richard

Authors

Dr NEIL NIXON Neil.Nixon@nottingham.ac.uk
CLINICAL ASSOCIATE PROFESSOR IN ADULT MOOD DISORDER

Catherine Kaylor-Hughes

Sandra Simpson

Anne Garland

Tim Dalgleish



Abstract

Background: Despite the known health costs of persistent depression, there is no established service framework for the treatment of this disorder and a lack of long-term outcome data to inform commissioning. To address this gap, we report the long-term clinical effectiveness of a randomised controlled trial (RCT) testing a specialist, collaborative model of care for people with persistent moderate to severe unipolar depression. Methods: A multicentre, pragmatic, single-blind, parallel-group randomised controlled trial comparing outcomes from a Specialist Depression Service (SDS) offering collaborative treatment with cognitive behavioural therapy (CBT) and pharmacotherapy for 12 months with treatment as usual (TAU) for persistent, moderate-severe depression in UK secondary care. Participants were initially assessed at baseline, 3, 6, 9, 12, and 18 months, with primary endpoints (17-item Hamilton Depression Rating Scale [HDRS17], and a Global Assessment of Functioning [GAF]) reported elsewhere (Morriss et al., 2016). Additional long-term, post-treatment, follow-up was made at 24 and 36 months with outcomes presented here. ClinicalTrials.gov (NCT01047124) and ISRCTN registration (ISRCTN 10963342). Results: At 24 months there remained a statistically significant between-group difference in HDRS17–2.69 (−5.14, −0.23) and a non-significant improvement in GAF 2.85 (−1.23, 6.94), both favouring the SDS. Simple statistics are presented at 36 months, due to attrition, showing higher continued response and remission vs TAU across all measures. Limitations: Potential bias through loss to follow-up, particularly beyond 24 months. Conclusions: Compared with standard secondary care, SDS management of persistent moderate-severe depression, produced long-term clinical benefits, sustained following treatment completion, suggesting a model for future specialist care.

Citation

Nixon, N., Guo, B., Kaylor-Hughes, C., Simpson, S., Garland, A., Dalgleish, T., & Morriss, R. (2024). Specialist treatment for persistent depression in secondary care: Sustained effects from a multicentre UK study at 24 and 36 months. Journal of Affective Disorders, 345, 70-77. https://doi.org/10.1016/j.jad.2023.10.105

Journal Article Type Article
Acceptance Date Oct 15, 2023
Online Publication Date Oct 19, 2023
Publication Date Jan 15, 2024
Deposit Date Oct 27, 2023
Publicly Available Date Oct 31, 2023
Journal Journal of Affective Disorders
Print ISSN 0165-0327
Electronic ISSN 1573-2517
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 345
Pages 70-77
DOI https://doi.org/10.1016/j.jad.2023.10.105
Keywords Depression; Pragmatic; RCT; Collaborative; Long-term Outcomes
Public URL https://nottingham-repository.worktribe.com/output/26527636
Publisher URL https://www.sciencedirect.com/science/article/pii/S016503272301296X?via%3Dihub